The role of post-operative plasma full-length glypican-3 in predicting the prognosis of hepatocellular carcinoma
-
- Mashima Hiroaki
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
-
- Mizuno Shoichi
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
-
- Fujinami Norihiro
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
-
- Saito Keigo
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
-
- Miura Masahiro
- Central Research Laboratories, Sysmex Corporation
-
- Suto Kouzou
- Central Research Laboratories, Sysmex Corporation
-
- Yoshida Tomokazu
- Central Research Laboratories, Sysmex Corporation
-
- Kobayashi Tsuyoshi
- Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
-
- Ohdan Hideki
- Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
-
- Uemura Yasushi
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
-
- Nakatsura Tetsuya
- Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
Bibliographic Information
- Other Title
-
- 術後血漿 FL-GPC3 値による肝細胞癌予後評価法の開発
Search this article
Journal
-
- Japan Journal of Molecular Tumor Marker Research
-
Japan Journal of Molecular Tumor Marker Research 36 (0), 34-35, 2021
Japanese Society for Molecular Tumor Marker Research
- Tweet
Details 詳細情報について
-
- CRID
- 1390568617218410624
-
- NII Article ID
- 130007987459
-
- ISSN
- 24338575
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles